APA (7th ed.) Citation

Lin, A., Giuliano, C. J., Palladino, A., John, K. M., Abramowicz, C., Yuan, M. L., . . . Sheltzer, J. M. (2019). Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials. Science translational medicine, 11(509), . https://doi.org/10.1126/scitranslmed.aaw8412

Chicago Style (17th ed.) Citation

Lin, Ann, et al. "Off-target Toxicity Is a Common Mechanism of Action of Cancer Drugs Undergoing Clinical Trials." Science Translational Medicine 11, no. 509 (2019). https://doi.org/10.1126/scitranslmed.aaw8412.

MLA (9th ed.) Citation

Lin, Ann, et al. "Off-target Toxicity Is a Common Mechanism of Action of Cancer Drugs Undergoing Clinical Trials." Science Translational Medicine, vol. 11, no. 509, 2019, https://doi.org/10.1126/scitranslmed.aaw8412.